Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 7/20 | 0.62 |
| ▸ | MMP8 | P22894 | 6/20 | 0.62 |
| ▸ | MMP12 | P39900 | 6/20 | 0.62 |
| ▸ | MMP13 | P45452 | 5/20 | 0.62 |
| ▸ | MMP3 | P08254 | 6/20 | 0.57 |
| ▸ | MMP10 | P09238 | 4/20 | 0.57 |
| ▸ | MMP9 | P14780 | 3/20 | 0.57 |
| ▸ | MMP14 | P50281 | 2/20 | 0.57 |
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.52 |
| ▸ | ERAP1 | Q9NZ08 | 3/20 | 0.52 |
| ▸ | LNPEP | Q9UIQ6 | 3/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.49 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.48 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14122328 | 1.00 | MMP2 (0.62) | MMP2MMP8MMP12MMP13MMP3 | |
| SCHEMBL14232807 | 1.00 | MMP2 (0.62) | MMP2MMP8MMP12MMP13MMP3 | |
| SCHEMBL14122732 | 1.00 | MMP2 (0.62) | MMP2MMP8MMP12MMP13MMP3 | |
| SCHEMBL6867825 | 1.00 | MMP2 (0.62) | MMP2MMP8MMP12MMP13MMP3 | |
| SCHEMBL14122147 | 0.96 | MMP2 (0.65) | MMP2MMP8MMP12MMP13MMP3 | |
| SCHEMBL6869217 | 0.96 | MMP2 (0.65) | MMP2MMP8MMP12MMP13MMP3 | |
| SCHEMBL14232887 | 0.96 | MMP2 (0.65) | MMP2MMP8MMP12MMP13MMP3 | |
| SCHEMBL14122841 | 0.91 | MMP12 (0.72) | MMP2MMP8MMP12MMP13MMP3 | |
| SCHEMBL19111742 | 0.91 | MMP12 (0.72) | MMP2MMP8MMP12MMP13MMP3 | |
| SCHEMBL6868541 | 0.91 | MMP12 (0.72) | MMP2MMP8MMP12MMP13MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2470514-B1 | PSEUDO-DIPEPTIDES AS MMP INHIBITORS | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-07-12 | — | — | EP | disclosed |
| US-20120309674-A1 | PSEUDODIPEPTIDES AS MMP INHIBITORS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALT (FR) | 2012-12-06 | — | — | US | disclosed |
| US-20120309674-A1 | PSEUDODIPEPTIDES AS MMP INHIBITORS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALT (FR) | 2012-12-06 | — | — | US | disclosed |
| WO-2011023864-A1 | PSEUDODIPEPTIDES AS MMP INHIBITORS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2011-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309674-A1 | PSEUDODIPEPTIDES AS MMP INHIBITORS | MMP3, MMP11, TIMP3 | MMP2 16/4885MMP8 40/4885MMP12 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.